SYNDAX PHARMACEUTICALS INC

Ticker: SNDX CUSIP: 87164F105 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 18,460 Value ($000) $388 Avg Close $17.45 Range $12.99 - $22.73
Q3 2025
Shares 17,179 Value ($000) $264 Avg Close $13.09 Range $8.59 - $17.24
Q2 2025
Shares 125,345 Value ($000) $1,174 Avg Close $11.01 Range $8.58 - $14.24
Q1 2025
Shares 35,037 Value ($000) $430 Avg Close $14.10 Range $12.06 - $16.95
Q3 2024
Shares 79,341 Value ($000) $1,527 Avg Close $20.66 Range $17.34 - $25.07
Q2 2024
Shares 144,566 Value ($000) $2,968 Avg Close $20.93 Range $18.65 - $24.38
Q1 2024
Shares 346,862 Value ($000) $8,255 Avg Close $22.30 Range $19.58 - $25.34
Q4 2023
Shares 143,266 Value ($000) $3,096 Avg Close $15.37 Range $11.21 - $21.84
Q3 2023
Shares 15,000 Value ($000) $218 Avg Close $18.92 Range $12.85 - $23.55
Q3 2022
Shares 10,737 Value ($000) $258 Avg Close $22.44 Range $18.05 - $25.71
Q4 2020
Shares 88,595 Value ($000) $1,970 Avg Close $20.74 Range $13.92 - $27.85